A Caroli

Summary

Affiliation: IRCCS Centro San Giovanni di Dio Fatebenefratelli
Country: Italy

Publications

  1. ncbi The dynamics of Alzheimer's disease biomarkers in the Alzheimer's Disease Neuroimaging Initiative cohort
    A Caroli
    LENITEM Laboratory of Epidemiology, Neuroimaging and Telemedicine, IRCCS S Giovanni di Dio FBF, Brescia, Italy
    Neurobiol Aging 31:1263-74. 2010
  2. ncbi Metabolic compensation and depression in Alzheimer's disease
    A Caroli
    LENITEM Laboratory of Epidemiology, Neuroimaging and Telemedicine, IRCCS S Giovanni di Dio Fatebenefratelli, Brescia, Italy
    Dement Geriatr Cogn Disord 29:37-45. 2010
  3. ncbi Functional compensation in incipient Alzheimer's disease
    A Caroli
    LENITEM Laboratory of Epidemiology, Neuroimaging, and Telemedicine, IRCCS San Giovanni di Dio FBF, 25125 Brescia, Italy
    Neurobiol Aging 31:387-97. 2010
  4. ncbi The new Alzheimer's criteria in a naturalistic series of patients with mild cognitive impairment
    S Galluzzi
    Laboratory of Epidemiology, Neuroimaging and Telemedicine LENITEM, IRCCS Centro San Giovanni di Dio Fatebenefratelli, via Pilastroni 4, 25125, Brescia, Italy
    J Neurol 257:2004-14. 2010
  5. ncbi Cerebral perfusion correlates of conversion to Alzheimer's disease in amnestic mild cognitive impairment
    A Caroli
    Laboratory of Epidemiology, Neuroimaging and Telemedicine, IRCCS San Giovanni di Dio FBF, via Pilastroni 4, 25125, Brescia, Italy
    J Neurol 254:1698-707. 2007
  6. ncbi In vivo mapping of amyloid toxicity in Alzheimer disease
    G B Frisoni
    Laboratory of Epidemiology and Neuroimaging, IRCCS San Giovanni di Dio FBF, via Pilastroni 4, I 25123 Brescia, Italy
    Neurology 72:1504-11. 2009
  7. ncbi Neuroimaging outcomes for clinical trials
    G B Frisoni
    G B Frisoni, IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy
    J Nutr Health Aging 11:348-52. 2007

Collaborators

Detail Information

Publications7

  1. ncbi The dynamics of Alzheimer's disease biomarkers in the Alzheimer's Disease Neuroimaging Initiative cohort
    A Caroli
    LENITEM Laboratory of Epidemiology, Neuroimaging and Telemedicine, IRCCS S Giovanni di Dio FBF, Brescia, Italy
    Neurobiol Aging 31:1263-74. 2010
    ..FDG-PET started changing early in time and likely followed a linear decline. In conclusion, this study provides the first evidence in favor of the dynamic biomarker model which has recently been proposed...
  2. ncbi Metabolic compensation and depression in Alzheimer's disease
    A Caroli
    LENITEM Laboratory of Epidemiology, Neuroimaging and Telemedicine, IRCCS S Giovanni di Dio Fatebenefratelli, Brescia, Italy
    Dement Geriatr Cogn Disord 29:37-45. 2010
    ..The aim of this study was to map metabolic compensation and depression in Alzheimer's disease (AD) on a voxel-by-voxel basis...
  3. ncbi Functional compensation in incipient Alzheimer's disease
    A Caroli
    LENITEM Laboratory of Epidemiology, Neuroimaging, and Telemedicine, IRCCS San Giovanni di Dio FBF, 25125 Brescia, Italy
    Neurobiol Aging 31:387-97. 2010
    ..These results help understand the reactive phenomena induced by the brain to try and counteract the pathological changes of AD...
  4. ncbi The new Alzheimer's criteria in a naturalistic series of patients with mild cognitive impairment
    S Galluzzi
    Laboratory of Epidemiology, Neuroimaging and Telemedicine LENITEM, IRCCS Centro San Giovanni di Dio Fatebenefratelli, via Pilastroni 4, 25125, Brescia, Italy
    J Neurol 257:2004-14. 2010
    ..82, 95% CI 0.70-0.95). MT atrophy and abnormal CSF are the single most robust predictors of conversion to AD in MCI patients, and their combination enhances prediction. AD markers are not predictive of conversion to non-AD dementia...
  5. ncbi Cerebral perfusion correlates of conversion to Alzheimer's disease in amnestic mild cognitive impairment
    A Caroli
    Laboratory of Epidemiology, Neuroimaging and Telemedicine, IRCCS San Giovanni di Dio FBF, via Pilastroni 4, 25125, Brescia, Italy
    J Neurol 254:1698-707. 2007
    ..Aim of this study was to find cerebral perfusion correlates of conversion to dementia in patients with amnestic MCI...
  6. ncbi In vivo mapping of amyloid toxicity in Alzheimer disease
    G B Frisoni
    Laboratory of Epidemiology and Neuroimaging, IRCCS San Giovanni di Dio FBF, via Pilastroni 4, I 25123 Brescia, Italy
    Neurology 72:1504-11. 2009
    ..To study the relationship between gray matter atrophy and amyloid deposition in Alzheimer disease (AD)...
  7. ncbi Neuroimaging outcomes for clinical trials
    G B Frisoni
    G B Frisoni, IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy
    J Nutr Health Aging 11:348-52. 2007
    ..The reviewed techniques, except for the most recent amyloid imaging, are those applied to prospective studies investigating changes of imaging markers over time...